Skip to main content
S 1063 108th Congress Senate Health Administrative procedure Commerce Communicable diseases Communication in medicine Cytology Data banks Department of Health and Human Services Food and Drug Administration (FDA) Government Operations and Politics Government paperwork Governmental investigations Health facilities Health information systems Labeling Law Licenses Medical screening Medical tests Packaging

Brian Lykins Human Tissue Transplant Safety Act of 2003

Introduced: May 14, 2003 Introduced by: Collins, Susan M. Republican · Maine See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2003
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 14, 2003
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Brian Lykins Human Tissue Transplant Safety Act of 2003 - Amends the Public Health Service Act to provide for oversight by the Commissioner of Food and Drugs of entities engaged in activities relating to human tissue or human tissue-based products, requiring their registration and authorizing their inspection. Requires the reporting of any adverse incidents. Requires the Commissioner to develop a reporting mechanism and a database to store such information.

Allows the Commissioner, in an instance in which this Act is violated, to: (1) issue an order requiring any distributor of a human cell, tissue, or cellular or tissue-based product to recall or destroy such product; (2) condemn, seize, and destroy such product; (3) require a covered entity to cease the activity that resulted in the violation; or (4) suspend or revoke the registration and listing of the covered entity involved.

What's happening now May 14, 2003

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 4151 Identical bill Brian Lykins Human Tissue Transplant Safety Act of 2004
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Durbin, Richard J.
Illinois · May 14, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1063: Brian Lykins Human Tissue Transplant Safety Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-S-1063/
MLA
"S. 1063: Brian Lykins Human Tissue Transplant Safety Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-1063/.
Bluebook (legal)
S. 1063, 108th Cong. (2026), https://openamerica.io/bill/108-S-1063/.
Markdown link
[S. 1063: Brian Lykins Human Tissue Transplant Safety Act of 2003](https://openamerica.io/bill/108-S-1063/)
Report a problem